Running the wannabe playbook

Running the wannabe playbook

Today we learned that ViCentra, the folks who make the Kaleido patch pump (the one that comes in pretty colors) have added two industry veterans to their team, one from Dexcom the other from Medtronic diabetes. This comes after the company added another $85 million to their coffers back in September.

Back when they announced the $85 Series D round the company said this –

“Kaleido is the smallest, lightest, and most precise insulin patch pump in its class, uniquely designed as a lifestyle product that is discreet, intuitive, and personalized. Designed to feel more like personal technology than a traditional . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.